↓ Skip to main content

Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions

Overview of attention for article published in Cancer Prevention Research, November 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
1 X user

Citations

dimensions_citation
207 Dimensions

Readers on

mendeley
150 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions
Published in
Cancer Prevention Research, November 2009
DOI 10.1158/1940-6207.capr-09-0121
Pubmed ID
Authors

Anne S. Tsao, Diane Liu, Jack Martin, Xi-ming Tang, J. Jack Lee, Adel K. El-Naggar, Ignacio Wistuba, Kirk S. Culotta, Li Mao, Ann Gillenwater, Yuko M. Sagesaka, Waun K. Hong, Vassiliki Papadimitrakopoulou

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
France 1 <1%
Germany 1 <1%
Mauritius 1 <1%
Canada 1 <1%
Unknown 144 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 13%
Researcher 17 11%
Student > Bachelor 17 11%
Student > Master 16 11%
Other 14 9%
Other 35 23%
Unknown 31 21%
Readers by discipline Count As %
Medicine and Dentistry 55 37%
Agricultural and Biological Sciences 19 13%
Biochemistry, Genetics and Molecular Biology 11 7%
Nursing and Health Professions 4 3%
Chemistry 3 2%
Other 20 13%
Unknown 38 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2023.
All research outputs
#1,615,628
of 23,578,918 outputs
Outputs from Cancer Prevention Research
#161
of 1,386 outputs
Outputs of similar age
#4,919
of 96,125 outputs
Outputs of similar age from Cancer Prevention Research
#3
of 18 outputs
Altmetric has tracked 23,578,918 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,386 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,125 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.